Andrew Reardon insider trades

Open-market stock purchases and sales by Andrew Reardon, CLO & Secretary at Ligand Pharmaceuticals Inc, from SEC Form 4 filings since Nov 30, 2022.

Recent trades

DateStockTradeValue
Oct 2, 2026LGND Ligand Pharmaceuticals IncSold$252K
Oct 2, 2026LGND Ligand Pharmaceuticals IncSold$600K
Oct 2, 2026LGND Ligand Pharmaceuticals IncSold$467K
Oct 2, 2026LGND Ligand Pharmaceuticals IncSold$124K
Oct 2, 2026LGND Ligand Pharmaceuticals IncSold$72.2K
Oct 2, 2026LGND Ligand Pharmaceuticals IncSold$5.2K
Oct 2, 2026LGND Ligand Pharmaceuticals IncBought (not open market)—
Sep 3, 2026LGND Ligand Pharmaceuticals IncSold$606K
Sep 3, 2026LGND Ligand Pharmaceuticals IncSold$85.2K
Sep 3, 2026LGND Ligand Pharmaceuticals IncSold$513K
Sep 3, 2026LGND Ligand Pharmaceuticals IncSold$116K
Sep 3, 2026LGND Ligand Pharmaceuticals IncSold$111K
Aug 3, 2026LGND Ligand Pharmaceuticals IncSold$29.8K
Aug 3, 2026LGND Ligand Pharmaceuticals IncSold$9.4K
Aug 3, 2026LGND Ligand Pharmaceuticals IncSold$44.9K
Aug 3, 2026LGND Ligand Pharmaceuticals IncSold$296K
Aug 3, 2026LGND Ligand Pharmaceuticals IncSold$349K
Aug 3, 2026LGND Ligand Pharmaceuticals IncSold$103K
Aug 3, 2026LGND Ligand Pharmaceuticals IncSold$146K
Aug 3, 2026LGND Ligand Pharmaceuticals IncSold$58.1K
Aug 3, 2026LGND Ligand Pharmaceuticals IncSold$289K
Aug 3, 2026LGND Ligand Pharmaceuticals IncSold$120K
Aug 3, 2026LGND Ligand Pharmaceuticals IncBought (not open market)$261K
Aug 3, 2026LGND Ligand Pharmaceuticals IncBought (not open market)—
Jul 1, 2026LGND Ligand Pharmaceuticals IncSold$122K

Companies traded

  • LGND Ligand Pharmaceuticals Inc: 66 sales, last Oct 2, 2026

Get free alerts when Andrew Reardon files a new trade →